Kayne Anderson Rudnick Investment Management
TMO icon

Kayne Anderson Rudnick Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.58M Sell
11,132
-489
-4% -$235K 0.02% 269
2026
Q1 		$5.71M Sell
11,621
-3,011
-21% -$1.63M 0.02% 258
2025
Q4 		$8.48M Sell
14,632
-850
-5% -$481K 0.02% 233
2025
Q3 		$7.51M Sell
15,482
-796
-5% -$371K 0.02% 242
2025
Q2 		$6.6M Sell
16,278
-1,137
-7% -$475K 0.02% 246
2025
Q1 		$8.67M Sell
17,415
-458
-3% -$248K 0.02% 245
2024
Q4 		$9.3M Sell
17,873
-1,014
-5% -$557K 0.02% 241
2024
Q3 		$11.7M Sell
18,887
-111
-0.6% -$65.7K 0.03% 228
2024
Q2 		$10.5M Sell
18,998
-3,291
-15% -$1.89M 0.03% 242
2024
Q1 		$13M Sell
22,289
-945
-4% -$530K 0.03% 235
2023
Q4 		$12.3M Buy
23,234
+243
+1% +$118K 0.03% 240
2023
Q3 		$11.6M Sell
22,991
-322
-1% -$172K 0.03% 241
2023
Q2 		$12.2M Sell
23,313
-16,486
-41% -$8.9M 0.03% 240
2023
Q1 		$22.9M Buy
39,799
+847
+2% +$477K 0.07% 176
2022
Q4 		$21.5M Buy
38,952
+2,298
+6% +$1.22M 0.07% 185
2022
Q3 		$18.6M Buy
36,654
+10,231
+39% +$5.73M 0.06% 188
2022
Q2 		$14.4M Sell
26,423
-51
-0.2% -$28.1K 0.05% 207
2022
Q1 		$15.6M Buy
26,474
+1,584
+6% +$910K 0.04% 212
2021
Q4 		$16.6M Buy
24,890
+262
+1% +$164K 0.04% 217
2021
Q3 		$14.1M Buy
24,628
+16,702
+211% +$9.17M 0.03% 216
2021
Q2 		$4M Buy
7,926
+363
+5% +$171K 0.01% 278
2021
Q1 		$3.45M Buy
7,563
+7,406
+4,717% +$3.53M 0.01% 276
2020
Q4 		$73K Buy
157
+119
+313% +$55.8K ﹤0.01% 424
2020
Q3 		$17K Hold
38
– – ﹤0.01% 454
2020
Q2 		$14K Sell
38
-8
-17% -$2.68K ﹤0.01% 434
2020
Q1 		$13K Hold
46
– – ﹤0.01% 433
2019
Q4 		$15K Buy
46
+38
+475% +$11.5K ﹤0.01% 414
2019
Q3 		$2K Buy
+8
New +$2.29K ﹤0.01% 523

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's TMO Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 4.2% in Q2 2026, selling an estimated $235K and leaving 11,132 shares worth $5.58M. The position accounts for 0.02% of the portfolio, ranked #269.

Kayne Anderson Rudnick Investment Management first reported a position in TMO in Q3 2019 and has held it in 28 quarters since. The position peaked at $22.9M in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 11,132 shares of Thermo Fisher Scientific worth $5.58M as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management sold 489 Thermo Fisher Scientific shares in Q2 2026, an estimated $235K.
  • Thermo Fisher Scientific made up 0.02% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #269 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 28 quarters since.
  • Kayne Anderson Rudnick Investment Management's Thermo Fisher Scientific position peaked at $22.9M in Q1 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.